Evaluation of gelatinases and IL-6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases
about
Multiple sclerosis: the role of cytokines in pathogenesis and in therapiesZymography methods for visualizing hydrolytic enzymes.Kallikrein 6 regulates early CNS demyelination in a viral model of multiple sclerosis.The potential use of MMP inhibitors to treat CNS diseases.Circulating levels of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases during Japanese encephalitis virus infection.Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases.Modeling Alexander disease with patient iPSCs reveals cellular and molecular pathology of astrocytes.Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants.Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions.Profiling of metalloprotease activities in cerebrospinal fluids of patients with neoplastic meningitis.Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of children with Japanese encephalitis virus infection.Interferon-beta inhibits the expression of metalloproteinases in rat glial cell cultures: implications for multiple sclerosis pathogenesis and treatment.Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study.Imaging matrix metalloproteinase activity in multiple sclerosis as a specific marker of leukocyte penetration of the blood-brain barrier.Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis.Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis.Cloning and expression in Escherichia coli of a human gelatinase B-inhibitory single-chain immunoglobulin variable fragment (scFv).Prevention of acute autoimmune encephalomyelitis and abrogation of relapses in murine models of multiple sclerosis by the protease inhibitor D-penicillamineProduction and Characterization of Recombinant Active Mouse Gelatinase B from Eukaryotic Cells and in vivo Effects after Intravenous AdministrationMonoclonal Antibodies Specific for Natural Human Neutrophil Gelatinase B Used for Affinity Purification, Quantitation by Two-Site ELISA and Inhibition of Enzymatic Activity
P2860
Q27011014-2F07B180-8A23-495C-AFBC-F9FB48C143D2Q34329995-1CDCE9C6-BACC-4528-9E90-595778DDACFCQ35987823-0A1D6392-19B1-4701-A9EE-EAEB06A9F0A9Q36181275-EBB28997-E1BC-4E12-B63C-4A7286099902Q36592590-26FC59D6-D1F4-4A80-87EA-F8581A503D27Q36836612-F60199DD-EAB3-4532-BA2E-DE45468F119FQ37084919-A2DE2AAE-1560-4EA2-9F41-E83BCC159EA8Q37595298-8F675D75-DEDE-4C93-9513-7E8AFA335153Q40857787-A0160D44-0F70-4AAE-8B51-F96AF8266E52Q41395645-D5376695-25BF-4681-BD2A-0529B1F506D8Q42285234-B0BBF8D4-582C-4FC0-97C6-D2D4CB34C324Q47276298-4A21D4A6-EACB-403D-861F-37DC104BE24AQ48267716-029F9F3E-3309-4C6D-ACA0-F324F0D479CBQ48434563-5398A46F-AA67-4081-A708-B5A84E90E64AQ48547710-FD45E3BB-859A-4A80-8B79-5AA7AE4E0C47Q50773267-EA10550A-3747-457F-92B8-CEE26B85C2E5Q54557749-2A2D53DF-391F-4BBF-A894-DFC8824366A7Q57247191-494A13B5-8AFD-4DCF-B1D2-7FED819987D8Q57584716-ADD43EEA-F5AD-425B-BCEB-0AE0B698A7D0Q57584759-F7511DAC-08E0-4C41-856C-D89D386E7F7D
P2860
Evaluation of gelatinases and IL-6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases
description
scientific article published on 01 September 1994
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 1994
@uk
name
Evaluation of gelatinases and ...... ammatory neurological diseases
@en
Evaluation of gelatinases and ...... ammatory neurological diseases
@nl
type
label
Evaluation of gelatinases and ...... ammatory neurological diseases
@en
Evaluation of gelatinases and ...... ammatory neurological diseases
@nl
prefLabel
Evaluation of gelatinases and ...... ammatory neurological diseases
@en
Evaluation of gelatinases and ...... ammatory neurological diseases
@nl
P2093
P2860
P921
P1476
Evaluation of gelatinases and ...... ammatory neurological diseases
@en
P2093
J van Damme
M Söderström
P2860
P356
10.1111/J.1468-1331.1994.TB00051.X
P577
1994-09-01T00:00:00Z